TGA – Current status of breast implant products in Australia
Published in Australia, Biological Evaluation, Breast Implants and Therapeutic Goods Administration - TGA
More from AustraliaMore posts in Australia »
- Australia – TGA – 3-D printing (additive manufacturing) of medical devices
- Australia – TGA – Actual and potential harm caused by medical software
- TGA – Regulation impact statement: Proposed regulatory scheme for personalised medical devices, including 3D-printed devices
- TGA – Medical device application processing times
- TGA guidance – Researcher considerations for medical devices Meeting the evidence requirements for market authorisation
More from Biological EvaluationMore posts in Biological Evaluation »
- EU – REACH Authorisation Decisions List
- Grey literature and medical devices
- Work in progress at the FDA for biological evaluation – Color Hazard and RISk calculator (CHRIS)
- US FDA paper – Epidemiological Evidence on the Adverse Health Effects Reports in Relation to Mercury from Dental Amalgam: Systematic Literature Review
- US FDA paper – Biological Responses to Metal Implants
More from Breast ImplantsMore posts in Breast Implants »
- EU – SCHEER – Minutes of the Working Group meeting on safety of breast implants in relation to anaplastic large cell lymphoma (BIA-ALCL) of 15 January 2020
- SCHEER Safety of breast implants WG – minutes of 4 November 2019 meeting
- US FDA Draft Guidance – Breast Implants – Certain Labeling Recommendations to Improve Patient Communication
- EU – Minutes of the 24 July 2019 SCHEER Working Group on safety of breast implants in relation to anaplastic large cell lymphoma (BIA-ALCL) meeting
- DSVG 04 – Breast Implants – Guidance on the vigilance system for CE-marked medical devices
More from Therapeutic Goods Administration - TGAMore posts in Therapeutic Goods Administration - TGA »
- Australia – TGA – 3-D printing (additive manufacturing) of medical devices
- Australia – TGA – Actual and potential harm caused by medical software
- TGA – Regulation impact statement: Proposed regulatory scheme for personalised medical devices, including 3D-printed devices
- TGA – Medical device application processing times
- TGA guidance – Researcher considerations for medical devices Meeting the evidence requirements for market authorisation
Be First to Comment